Two totally different things.

Original and current trial design: 2400 patients with average dosing of 1.5 years = 3600 patient years

Hypothetical change to patient enrollment due to sample size re-estimation analysis = 3600 patients. SSRA could results in no change, small change or big change in sample size/patient enrollment.